Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GNVC:US

3.3900 USD 0.1000 3.04%

As of 20:10:00 ET on 01/30/2015.

Snapshot for GenVec Inc (GNVC)

Open: 3.2100 Day's Range: 3.1900 - 3.6000 Volume: 47,274
Previous Close: 3.2900 52wk Range: 1.6110 - 4.1200 1-Yr Rtn: -7.63%

Stock Chart for GNVC

No chart data available.
  • GNVC:US 3.3900
  • 1D
  • 1M
  • 1Y
3.2900
Interactive GNVC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNVC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3400
Est. EPS (USD) (12/2014) -0.1750
Est. PEG Ratio -
Market Cap (M USD) 58.55
Shares Outstanding (M) 17.27
30 Day Average Volume 112,678
Price/Book (mrq) 5.1171
Price/Sale (ttm) 17.8071
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNVC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GNVC

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal cancer, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.

Douglas J SwirskyPresident/CEO/SecretaryDouglas E BroughChief Scientific Officer
James V LambertCFO/Treasurer/ControllerBryan T ButmanSenior VP:Development
More Company Profile & Key Executives for GNVC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil